NICE recommends it (Technology Appraisal TA664) for a more restricted population than semaglutide specifically adults with a BMI of 35 kg/m or above (with lower thresholds for certain ethnic groups) who also have prediabetes and a high risk of cardiovascular disease, and only when used within a specialist weight management service
These properties can be affected by pharmacological agents or growth factors, such as different GLP-1-RA in various concentrations
Giblin K, Kaplan LM, Somers VK, Le Roux CW, Hunter DJ, et al
Int J Obes 28, 13991410 (2004)
The research shows this form actually works
As we age, growth hormone levels naturally decline, often resulting in increased body fat, decreased muscle mass, reduced energy levels, and slower metabolism